Brief: Endovia Health Sciences - Enters Letter Agreement With C/M Capital Master Fund On Oct 15, 2026 - SEC Filing
BRIEF-Endovia Health Sciences - Enters Letter Agreement With C/M Capital Master Fund On Oct 15, 2026 - SEC Filing Oct 15 (Reuters) - Endovia Health Sciences, Inc. EDVA.A:
ENDOVIA HEALTH SCIENCES - ENTERS LETTER AGREEMENT WITH C/M CAPITAL MASTER FUND ON OCT 15, 2026 - SEC FILING
ENDOVIA HEALTH SCIENCES - INCREASES BENEFICIAL OWNERSHIP LIMITATION TO 9.99% EFFECTIVE IMMEDIATELY - SEC FILING
ENDOVIA HEALTH SCIENCES - WAIVES NOTICE REQUIREMENTS AND INCONSISTENT PROVISIONS IN PURCHASE AGREEMENT - SEC FILING
Source text: [ID:n0001731122-26-001347]
Further company coverage: EDVA.A
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Endovia Health Sciences
See all newsBrief: Endovia Health Sciences - Enters Letter Agreement With C/M Capital Master Fund On Oct 15, 2026 - SEC Filing
Brief: Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026
Brief: Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
Brief: Splash Beverage Reports Second Quarter 2026 Results And Highlights Strategic Transformation Toward Endovia Health Sciences
Expands Cannepil License To Veterinary Therapeutics